Ile73Asn mutation in protein C introduces a new N-linked glycosylation site on the first EGF-domain of protein C and causes thrombosis.


Journal

Haematologica
ISSN: 1592-8721
Titre abrégé: Haematologica
Pays: Italy
ID NLM: 0417435

Informations de publication

Date de publication:
06 2020
Historique:
received: 15 05 2019
accepted: 07 08 2019
pubmed: 11 8 2019
medline: 28 4 2021
entrez: 11 8 2019
Statut: ppublish

Résumé

Activated protein C exerts its anticoagulant activity by protein S-dependent inactivation of factors Va and VIIIa by limited proteolysis. We identified a venous thrombosis patient who has plasma protein C antigen level of 63% and activity levels of 44% and 23%, as monitored by chromogenic and clotting assays. Genetic analysis revealed the proband carries compound heterozygous mutations (c.344T>A, p.I73N and c.1181G>A, p.R352Q) in

Identifiants

pubmed: 31399531
pii: haematol.2019.227033
doi: 10.3324/haematol.2019.227033
pmc: PMC7271577
doi:

Substances chimiques

Protein C 0
Epidermal Growth Factor 62229-50-9
Thrombin EC 3.4.21.5

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1712-1722

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL062565
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL101917
Pays : United States

Informations de copyright

Copyright© 2020 Ferrata Storti Foundation.

Références

J Biol Chem. 1995 Nov 17;270(46):27852-8
pubmed: 7499257
J Clin Invest. 1998 Oct 15;102(8):1481-8
pubmed: 9788960
Blood. 2011 Jun 16;117(24):6685-93
pubmed: 21508412
Biochemistry. 2002 May 14;41(19):6149-57
pubmed: 11994010
J Biol Chem. 2004 Nov 12;279(46):48262-9
pubmed: 15347660
Blood. 1987 Feb;69(2):692-4
pubmed: 2948582
Biochem J. 2000 Aug 1;349 Pt 3:757-64
pubmed: 10903136
Thromb Res. 1995 Jan 1;77(1):1-43
pubmed: 7701473
J Biol Chem. 1981 Nov 10;256(21):11128-31
pubmed: 6457049
Biochemistry. 2009 Sep 1;48(34):8261-70
pubmed: 19640005
Blood. 2015 Apr 9;125(15):2428-34
pubmed: 25651845
Proc Natl Acad Sci U S A. 1993 Feb 1;90(3):1004-8
pubmed: 8430067
Thromb Haemost. 2017 Jun 28;117(7):1358-1369
pubmed: 28405673
Proteins. 1994 Apr;18(4):367-80
pubmed: 8208728
J Clin Invest. 1981 Nov;68(5):1370-3
pubmed: 6895379
Nature. 1994 May 5;369(6475):64-7
pubmed: 8164741
J Biol Chem. 1997 Oct 3;272(40):25013-21
pubmed: 9312108
J Biol Chem. 2006 Sep 29;281(39):28850-7
pubmed: 16867987
J Biol Chem. 1995 Sep 8;270(36):21158-66
pubmed: 7673148
J Biol Chem. 1991 May 25;266(15):9778-85
pubmed: 2033065
J Biol Chem. 1988 Dec 15;263(35):19240-8
pubmed: 2461936
Blood. 1986 Oct;68(4):881-5
pubmed: 2944555
J Biol Chem. 2003 Jul 4;278(27):24904-11
pubmed: 12707283
Biochemistry. 1995 Sep 26;34(38):12221-6
pubmed: 7547963
Thromb Haemost. 1993 Jul 1;70(1):29-35
pubmed: 8236111
Blood. 1991 Oct 1;78(7):1637-51
pubmed: 1912552
Proc Natl Acad Sci U S A. 1984 Aug;81(15):4766-70
pubmed: 6589623
Thromb Haemost. 2007 Jun;97(6):899-906
pubmed: 17549291
Blood. 2010 Jun 10;115(23):4878-85
pubmed: 20308596
EMBO J. 1989 Nov;8(11):3467-75
pubmed: 2583108
EMBO J. 1996 Dec 16;15(24):6822-31
pubmed: 9003757
J Biol Chem. 2004 Sep 10;279(37):38519-24
pubmed: 15254039
Int J Lab Hematol. 2013 Feb;35(1):1-13
pubmed: 22978493
J Biol Chem. 1999 Feb 26;274(9):5462-8
pubmed: 10026158
FASEB J. 1992 May;6(8):2561-7
pubmed: 1317308
J Biol Chem. 1993 Dec 25;268(36):27246-57
pubmed: 8262965
J Biol Chem. 1999 Feb 19;274(8):4970-6
pubmed: 9988741
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10653-6
pubmed: 8855234
Biophys Chem. 2004 Dec 20;112(2-3):253-6
pubmed: 15572256
J Comput Aided Mol Des. 1997 May;11(3):293-304
pubmed: 9263856
Thromb Haemost. 1993 Jan 11;69(1):77-84
pubmed: 8446940

Auteurs

Yeling Lu (Y)

Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Padmaja Mehta-D'souza (P)

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Indranil Biswas (I)

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA.

Bruno O Villoutreix (BO)

Université Lille, Inserm, Institut Pasteur de Lille, U1177 - Drugs and Molecules for Living Systems, F-59000 Lille, France.

Xuefeng Wang (X)

Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.

Qiulan Ding (Q)

Department of Laboratory Medicine, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China qiulan_ding@hotmail.com.

Alireza R Rezaie (AR)

Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA ray-rezaie@omrf.org.
Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH